Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:AST NYSE:MEN NASDAQ:PET On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASTAsterias Biotherapeutics$0.00$0.00$0.51▼$2.05$111KN/A136,653 shs1,000 shsMENBlackRock MuniEnhanced Fund$12.08$12.01$9.95▼$12.57N/AN/A55,540 shs28,963 shsPETWag! Group$0.05-58.9%$0.10$0.04▼$1.26$2.44M1.6612.53 million shs28.29 million shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASTAsterias Biotherapeutics0.00%0.00%0.00%0.00%0.00%MENBlackRock MuniEnhanced Fund0.00%0.00%0.00%0.00%0.00%PETWag! Group0.00%0.00%0.00%-65.91%-94.26%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASTAsterias Biotherapeutics$0.00$0.00$0.51▼$2.05$111KN/A136,653 shs1,000 shsMENBlackRock MuniEnhanced Fund$12.08$12.01$9.95▼$12.57N/AN/A55,540 shs28,963 shsPETWag! Group$0.05-58.9%$0.10$0.04▼$1.26$2.44M1.6612.53 million shs28.29 million shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASTAsterias Biotherapeutics0.00%0.00%0.00%0.00%0.00%MENBlackRock MuniEnhanced Fund0.00%0.00%0.00%0.00%0.00%PETWag! Group0.00%0.00%0.00%-65.91%-94.26%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASTAsterias Biotherapeutics 0.00N/AN/AN/AMENBlackRock MuniEnhanced Fund 0.00N/AN/AN/APETWag! Group 2.33Hold$6.0012,374.01% UpsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AN/AMENBlackRock MuniEnhanced FundN/AN/AN/AN/AN/AN/APETWag! Group$70.51M0.03N/AN/A($0.01) per share-4.81Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASTAsterias BiotherapeuticsN/AN/A0.00∞N/AN/AN/AN/AN/AMENBlackRock MuniEnhanced FundN/AN/A0.00∞N/AN/AN/AN/AN/APETWag! Group-$17.57M-$0.39N/A∞N/A-29.17%N/A-58.54%11/10/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AMENBlackRock MuniEnhanced Fund$0.584.80%N/AN/AN/APETWag! GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASTAsterias BiotherapeuticsN/AN/AN/AMENBlackRock MuniEnhanced FundN/AN/AN/APETWag! GroupN/A0.460.46Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASTAsterias BiotherapeuticsN/AMENBlackRock MuniEnhanced FundN/APETWag! Group86.16%Insider OwnershipCompanyInsider OwnershipASTAsterias BiotherapeuticsN/AMENBlackRock MuniEnhanced FundN/APETWag! Group20.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASTAsterias BiotherapeuticsN/A55.66 millionN/ANot OptionableMENBlackRock MuniEnhanced FundN/AN/AN/ANot OptionablePETWag! Group9050.74 million40.24 millionNot OptionableMEN, CLON, AST, and PET HeadlinesRecent News About These CompaniesWag! Group Co. Successfully Completes Pre-Packaged Chapter 11 Plan of ReorganizationSeptember 2 at 6:00 AM | globenewswire.comAnalyzing Wag! Group (NASDAQ:PET) and Cimpress (NASDAQ:CMPR)September 1, 2025 | americanbankingnews.comWag! Group Co. Faces Financial Challenges Amid Chapter 11August 14, 2025 | msn.comWag! Group Co.July 30, 2025 | barrons.comSan Francisco's Wag! Group Co. Files for Bankruptcy, Plans for Restructuring with Retriever LLC Taking OwnershipJuly 30, 2025 | hoodline.comHWag! Group stock plunges after Nasdaq delisting noticeJuly 30, 2025 | za.investing.comBig pet insurance, animal care brand files Chapter 11 bankruptcyJuly 23, 2025 | msn.comDog-Walking App Wag! Gets Nod to Try for Speedy Bankruptcy ExitJuly 23, 2025 | msn.comWag! Group Co. Announces Recapitalization Transaction with Retriever LLCJuly 21, 2025 | globenewswire.comFriendship dog charity gains dozens of volunteersJuly 20, 2025 | msn.comPET - Wag Group Co Trailing Returns - MorningstarJuly 18, 2025 | morningstar.comMWag! Group Co. (NASDAQ:PET) Major Shareholder Sells $173,800.00 in StockJuly 18, 2025 | insidertrades.comWag! Group Co. Announces Sale of Furscription to MWI Veterinary Supply Co.July 15, 2025 | finance.yahoo.comPET - Wag Group Co Valuation - MorningstarJuly 9, 2025 | morningstar.comMWag! Group Stock Experiences Volatility in Pre-Market TradingJuly 9, 2025 | benzinga.comWag Group (NASDAQ:PET) Stock, Short Interest ReportJuly 1, 2025 | benzinga.comWag! Group Co. (PET) - Yahoo FinanceJuly 1, 2025 | finance.yahoo.comWag! Group Co News (PET) - Investing.comJune 28, 2025 | investing.comPets Supplies Plus and Wag N’ Wash in Livonia on Pace to Open 25 Stores by End of YearJune 10, 2025 | dbusiness.comDPet Supplies Plus and Wag N' Wash Report Double Digit Mid-Year Growth Amid Record Industry HighsJune 9, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines3 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 2025NIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 20253 AI Infrastructure Stocks Powering the Next Tech RevolutionBy Ryan Hasson | August 8, 2025IBM: The Last Time This Happened, the Stock Rallied 35%By Sam Quirke | August 12, 2025Can AI Defense Contracts Push Palantir Shares Higher?By Chris Markoch | August 19, 2025MEN, CLON, AST, and PET Company DescriptionsAsterias Biotherapeutics NYSEAMERICAN:AST$0.0020 0.00 (0.00%) As of 07/10/2019Asterias Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing cell-based therapeutics to treat neurological conditions associated with demyelination, and cellular immunotherapies to treat cancer. Its clinical stage programs include AST-OPC1, an oligodendrocyte progenitor cell population derived from pluripotent stem cells that is in Phase I/IIa clinical trial for spinal cord injuries; AST-VAC2 is a non-patient-specific cancer immunotherapy derived from pluripotent stem cells for the treatment of non-small cell lung cancer; and AST-VAC1, a patient-specific cancer immunotherapy that has completed Phase II clinical trial for the treatment of acute myeloid leukemia. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is headquartered in Fremont, California.BlackRock MuniEnhanced Fund NYSE:MENBlackRock MuniEnhanced Fund, Inc. operates as a closed-end investment fund. The firm intends to provide shareholders with current income exempt from federal income taxes. It invests in long-term municipal bonds rated investment grade quality at the time of investment and invests primarily in long-term municipal bonds with maturities over the time of investment. The company was founded on March 2, 1989 and is headquartered in Wilmington, DE.Wag! Group NASDAQ:PETWag! Group Co. develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent pet caregivers to connect with pet parents. Its platform allows pet parents, who require specific pet care services, such as dog walking, pet sitting and boarding, advice from licensed pet experts, home visits, training, and pet insurance comparison tools. The company was founded in 2014 and is headquartered in San Francisco, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Hedge Fund Elliott Bet $4B on Pepsi and Sees Over 50% Upside Palantir Insider Selling: Risk Signal or Normal Activity? Buy the Dip? GitLab’s Bullish Case Outweighs the Bears Affirm Crushes Earnings Expectations, Turns Bears into Believers Gold’s Explosive Rally: GDX ETF May Be the Fast Track to Profits Microsoft’s AI Push Beyond OpenAI Could Drive Next Breakout Dollar Tree Plunges Into Buy-Zone: A Robust Rebound Is Expected Zscaler Shares Can Hit a Fresh High Before Year-End Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
